Procedures

Radiofrequency coagulation for osteoblastic osteoma

Osteoid osteoma is a benign osteoblastic (bone producing) tumor. The literature suggests that its natural history is a history of resolving pain and healing of the lesions, but the course can be variable. The course of this disease is unpredictable and protracted, with intervals of resolution of pain that sometimes last 6-15 years. Initial treatment of osteoid osteoma remains nonoperative, with medications such as aspirin on other non-steroidal pain

Read more
Primary Sclerosing Cholangitis (PSC)

Primary sclerosing cholangitis (PSC) is a chronic, liver disease characterized by bile stasis within bile ducts and liver inflammation and fibrosis. It is thought to be an immune mediated, progressive disorder that eventually develops into liver cirrhosis, portal hypertension and hepatic decompensation, in the majority of patients. How does one follow the activity of this disease? Guidelines do not recommend routine MRCP or ERCP to screen for screening

Read more
Routine MCP or ERCP Surveillance for Cholagniocarcinoma or Liver Cancer in Patients with Primary Biliary Cirrhosis.

Primary sclerosing cholangitis (PSC) is a chronic, cholestatic liver disease characterized by inflammation and fibrosis of both intrahepatic and extrahepatic bile ducts. It is thoughtto be an immune mediated, progressive disorder that eventually develops into cirrhosis, portal hypertension and hepatic decompensation, in the majority of patients. Guidelines do not recommend routine MRCP or ERCP to screen for chalngiocarcinoma or hepatocellular carcinoma.

Read more
Neupogen for stem cell mobilization: Dose and Duration

Neupogen(filgrastim)  is often used to drive progenitor cells into the peripheral blood so they can collected by the leukophereses for use in a stem cell transplant. It is FDA approved for this purpose. Regarding dose, please look at the professional version. How long should Neupogen be used? It is recommended that NEUPOGEN® (filgrastim) be given for at least 4 days before the first leukapheresis procedure and continued until the last leukapheresis.

Read more
TACE for Liver Metastases from Ovarian Cancer

Transcatheter arterial chemoembolization (TACE) of the liver is an alternative to conventional systemic or intra-arterial chemotherapy, and to various nonsurgical tumor-killing techniques. It is meant to treat resectable and non-resectable tumors. The rationale for TACE is that infusions of viscous material containing one or more chemo drugs may have synergy: chemotherapy killing cancer cells that are already weakened from a lack of oxygen in the

Read more
Combined Resection for Anal Cancer

The term ‘combined resection” refers to removing the primary cancer and one or a few metastatic area, in the hope that there are no metastases and that it will lead to a cure or prolonged period of being free of cancer. While a combined resection of rectal cancer and partial liver resection of metastases is well established, the same is not the case for anal cancer. Metastatic anal cancer is not well studied in regard to a combined resection.

Read more
Sacroiliac Injection

Sacroiliac steroid injection can be used diagnostically or therapeutically. There are no prospective a controlled trials to support this procedure. Most support comes from case reports or case series. Case series are unreliable evidence due to the variable natural history of back pain, the presence of factors that can influence outcome and mislead the investigators, and the potential for a placebo effect. In general, the literature regarding injection

Read more